Zobrazeno 1 - 10
of 111
pro vyhledávání: '"O Van Cutsem"'
Publikováno v:
Journal of the Belgian Society of Radiology, Vol 98, Iss 2, Pp 88-90 (2015)
We report a case of rapidly growing pleural empyema due to endobronchial lipoma. The diagnosis was established by chest computed tomography (CT). Endobronchial lipoma is a rare benign tumor of the tracheobronchial tree which can cause irreversible da
Externí odkaz:
https://doaj.org/article/c295e5282e9a4590a4a52f6f495418c7
Publikováno v:
Diagnostic and Interventional Imaging. 98:93-95
Autor:
Jean-Paul Sculier, Marianne Paesmans, Nathalie Leclercq, Vicente Giner, O Van Cutsem, Arnaud Scherpereel, Thierry Berghmans, Jean-Sébastien Lecomte, P. Van Houtte, Anna Efremidis, Jean-Jacques Lafitte, Anne-Pascale Meert
Publikováno v:
European Respiratory Journal. 38:657-663
It is commonly considered that idiopathic pulmonary fibrosis (IPF) predisposes to the occurrence of lung cancer (LC). The frequency of IPF and LC coexistence is assessed at 4,8% to 48,2% depending on the country of origin and type of the report. Base
Publikováno v:
Journal of the Belgian Society of Radiology; Vol 98, No 2 (2015); 88-90
Journal of the Belgian Society of Radiology, Vol 98, Iss 2, Pp 88-90 (2015)
Journal of the Belgian Society of Radiology, Vol 98, Iss 2, Pp 88-90 (2015)
We report a case of rapidly growing pleural empyema due to endobronchial lipoma. The diagnosis was established by chest computed tomography (CT). Endobronchial lipoma is a rare benign tumor of the tracheobronchial tree which can cause irreversible da
Autor:
P Recloux, O Van Cutsem, Jean-Paul Sculier, Michel Richez, Jean-Jacques Lafitte, Vincent Ninane, Marianne Paesmans, Thierry Berghmans, Jean Klastersky, Paul Mommen
Publikováno v:
Lung Cancer. 37:73-77
The purpose of this study was to determine the activity of paclitaxel as a second-line chemotherapy for non-small cell lung cancer (NSCLC). This multicentric trial included patients who had failed to a first-line chemotherapy with platinum derivative
Autor:
M.C. Berchier, Marianne Paesmans, J. Michel, Thierry Berghmans, J. Lecomte, V. Giner, George Koumakis, Jean Klastersky, Jean-Jacques Lafitte, Jean-Paul Sculier, Jacques Thiriaux, Vincent Ninane, M.C. Florin, Paul Mommen, O Van Cutsem
Publikováno v:
British Journal of Cancer
British Journal of Cancer, 85 (10
British Journal of Cancer, 85 (10
SCOPUS: ar.j
info:eu-repo/semantics/published
info:eu-repo/semantics/published
Autor:
Gérard Bureau, Paul Mommen, Vincent Ninane, Jean-Paul Sculier, Marianne Paesmans, P. Libert, Roger Sergysels, G Dabouis, Jean Klastersky, J. Lecomte, Jacques Thiriaux, O Van Cutsem
Publikováno v:
Cancer. 89:523-533
BACKGROUND The purposes of this study were to identify prognostic factors for response to chemotherapy, overall survival, and long term survival of patients with small cell lung carcinoma and to construct a classification of patients on the basis of
Autor:
Paul Mommen, Roger Sergysels, Jean Klastersky, G Dabouis, Jacques Thiriaux, J. Michel, Marianne Paesmans, O Van Cutsem, Jean-Paul Sculier, Gérard Bureau, P. Libert
Publikováno v:
European Journal of Cancer. 33:2326-2332
The aim of this study was the assessment of the predictive value for survival of an antitumoral response to three courses of chemotherapy in association with various pretreatment characteristics in patients with non-resectable non-small cell lung can
Autor:
M. Borges, M.C. Berchier, O Van Cutsem, Jean-Paul Sculier, Roger Sergysels, Jacqueline Schmerber, Gérard Bureau, Marianne Paesmans, J. Michel, Jean Klastersky, G Dabouis, J. Lecomte, Paul Mommen, Michel Richez, V. Giner
Publikováno v:
Lung Cancer. 16:21-33
Purpose: To identify pretreatment variables predicting response to platinum derivatives containing chemotherapy in patients with unresectable non-small cell lung cancer (NSCLC). Patients and methods: Eligible patients included in one of the 7 consecu
Autor:
M.C. Berchier, Jean-Paul Sculier, Friedrich Kroll, V. Giner, Udo Küstner, Jean Klastersky, Gérard Bureau, Marianne Paesmans, O Van Cutsem, Paul Mommen, J. Michel, Roger Sergysels, Jean-Sébastien Lecomte
Publikováno v:
Journal of Clinical Oncology. 14:2337-2344
PURPOSE AND METHODS The European Lung Cancer Working Party (ELCWP) performed a randomized trial with the primary end point to determine if maintenance chemotherapy with 12 courses of etoposide (120 mg/m2 on days 1 and 3) and vindesine (3 mg/m2 on day